INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 8 filers reported holding INNATE PHARMA S A in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,000 | -40.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2021 | $5,000 | -58.3% | 1,000 | -50.0% | 0.00% | – |
Q3 2021 | $12,000 | +300.0% | 2,000 | +100.0% | 0.00% | – |
Q2 2021 | $3,000 | -66.7% | 1,000 | -50.0% | 0.00% | – |
Q1 2021 | $9,000 | +12.5% | 2,000 | 0.0% | 0.00% | – |
Q3 2020 | $8,000 | -42.9% | 2,000 | 0.0% | 0.00% | – |
Q2 2020 | $14,000 | +7.7% | 2,000 | 0.0% | 0.00% | – |
Q1 2020 | $13,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EXCHANGE TRADED CONCEPTS, LLC | 34,998 | $88,545 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 46,973 | $118,842 | 0.00% |
MORGAN STANLEY | 44,954 | $113,734 | 0.00% |
Steward Partners Investment Advisory, LLC | 500 | $1,265 | 0.00% |
Optiver Holding B.V. | 190,219 | $481,254 | 0.00% |
BARCLAYS PLC | 412 | $1 | 0.00% |
UBS Group AG | 146 | $369 | 0.00% |
RHUMBLINE ADVISERS | 205 | $518 | 0.00% |